Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Royalty Pharma inks US$ 2 bn cancer drug deal with Revolution; Astra-Daiichi's Datroway wins US approval for lung cancer

In news this week, Royalty Pharma committed up to US$ 2 billion to Revolution Medicines for their promising pancreatic and lung...

Impressions : 2824

Lilly acquires gene-editing firm Verve for US$ 1.3 bn, BioNTech buys CureVac; Astra signs US$ 5.3 bn AI deal with China's CSPC

This week’s Phispers comes with news on several M&A deals. Eli Lilly made headlines with its US$ 1.3 billion acquisit...

Impressions : 526

RFK Jr fires all 17 members of CDC's vaccine committee; Merck's oral cholesterol drug meets goals in late-stage trials

This week, US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. dismissed all 17 members of the US Centers for D...

Impressions : 1042

BMS partners BioNTech in US$ 11 bn cancer drug deal; Sanofi to acquire Blueprint Medicines for US$ 9.5 bn

The pharmaceutical sector saw several significant deals with major players expanding their portfolios. Bristol Myers Squibb (BM...

Impressions : 518

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Royalty Pharma inks US$ 2 bn cancer drug deal with Revolution; Astra-Daiichi's Datroway wins US approval for lung cancer

Lilly acquires gene-editing firm Verve for US$ 1.3 bn, BioNTech buys CureVac; Astra signs US$ 5.3 bn AI deal with China's CSPC

RFK Jr fires all 17 members of CDC's vaccine committee; Merck's oral cholesterol drug meets goals in late-stage trials

BMS partners BioNTech in US$ 11 bn cancer drug deal; Sanofi to acquire Blueprint Medicines for US$ 9.5 bn

Regeneron's Biologics Lynozyfic Receive Approval in US

Eli Lilly's Biologics Kisunla Receive Suppl Approval in US

BMS's Biologics Opdivo Receive Suppl Approval in US

Annora Pharma's Generics Prucalopride Receives Approval in US

Aggrega's Generics Prucalopride Receives Approval in US

H2-Pharma's Generics Prucalopride Receives Approval in US

Unique's Generics Alcohol Receives Approval in US

Unique's Generics Amitriptyline HCl Receives Approval in US

Torrent's Generics Apremilast Receives Approval in US

GSK's Biologics Benlysta Receives Suppl Approval in US

Enforcement Report - Week of July 2, 2025

Staska Pharmaceuticals Recieves Warning Letter

Sandoz Issues a Nationwide Recall of Cefazolin

Enforcement Report - Week of June 25, 2025

Zhejiang Medicinel is on Health Canada Inspection List

Yiling Pharmaceutical is on Health Canada Inspection List

Emix Limited's Fails EDQM inspection

Enforcement Report - Week of June 18, 2025

Huahai Pharma Recieves Warning Letter

Kenil Healthcare Recieves Warning Letter

FDA Confirms Para IV Patent Litigation for Veklury Powder for Inj

Sandoz Pumps $440 M Into Another Slovenia Biosimilar Plant

Organon axes 'biggest potential opportunity' after trial fail

RFK Jr. Eyes Changes to Vaccine Injury Compensation Program

US FDA Approves Regeneron's Blood Cancer Therapy

Regeneron's Biologics Lynozyfic Receive Approval in US

Enforcement Report - Week of July 2, 2025

Sanofi takes up option on Adagene biospecific, invests $25M

EU Approves Vertex's Next-Generation Cystic Fibrosis Drug

Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug

FDA Confirms Para IV Patent Litigation for Veklury Powder for Inj

Alembic Gets US FDA Approval for Doxorubicin Liposome

Alembic Announces USFDA Final Approval for Single-Dose Vials

India's Biocon Drops Plan to Launch Weight-Loss Drugs in China

Lupin Launches Prucalopride Tablets in U.S.

Lupin receives USFDA approval for Prucalopride Tablets

Accord Healthcare Launches Dehydrated Alcohol Injection

DHODH Inhibitors Market to Reach New Heights by 2034 in Oncology

Study: Delaying Authorized Generics Is on The Decline

Cigna Files Anti-Competition Lawsuit Against BMS Over Pomalyst

Sandoz Pumps $440 M Into Another Slovenia Biosimilar Plant

RFK Jr. Eyes Changes to Vaccine Injury Compensation Program

US FDA Approves Regeneron's Blood Cancer Therapy

Shionogi Offers $600 M for Swiss Biotech's Antibiotic Program

RFK Jr. Enlists Team to Revamp Vaccine Injury Compensation in US

Argenx Makes $1.5B+ Play for UNP's Macrocyclic Peptides

Sensorion Reports Positive Data from Audiogene Phase 1/2 Trial

Amgen, Zai Say Stomach Cancer Candidate Hits Phase 3 Mark

AbbVie to buy Capstan for up to $2.1B in Immunology Push

INmune Bio's Alzheimer's Drug Falls Short of Mid-Stage Study Goal

Axcelead, A2 Healthcare Partner to Accelerate Drug R&D

Nippon Shokubai to Expand Nucleic Acid API Capacity 10x

DBT to Support Biomanufacturing of APIs to reduce GHG emissions

Sigachi Gets ToR Approval For API & Chemicals Manufacturing

Zydus gets EIR for API facility at Ankleshwar & Dabhasa

India Must Enhance Role as Global Supply Chain Innovator

Lubrizol's Apisolex Polymer Excipient in Phase I Candidate

Carbogen Amcis to Co-Invest CHF 25M+ in Swiss Expansion

Lubrizol Announces Milestone for Apisolex™ Polymer

Santosh Mahil appointed CEO of Sekhmet Pharmaventures

Govt to Bring in Barcodes to Fight Fake Drug Menace

Plans to Restrict Open Market Access to Tuberculosis Medicines

Aurobindo Pharma recalls 4,608 pain reliever bottles in US

CDC Panel Recommends Against Use of Thimerosal in Flu Vaccines

Pondicherry Pharma MSMEs Face Deadline in CDSCO's cGmp Crackdown

FDA Warns Sterling Distributors for DSCSA Compliance Issues

Glenmark's Facility Gets 5 FDA Observations Post-Inspection

Gland Pharma Gets USFDA EIR for Visakhapatnam Facility

Concord Biotech's API facility completes USFDA inspection

Fixing Extractables & Leachables Studies for Regulatory Review

Onward Medical Files 510(k) for ARC-EX System Home Use

Bay Psychiatric Hosts Open House for Healthcare Providers

Keystone Folding Box Co., Med-Con Technologies Enhance Key-Pak